Literature DB >> 2060162

Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome.

Y L Pennec1, G Magadur, J Jouquan, P Youinou.   

Abstract

Twenty-four out of 54 patients with primary Sjögren's syndrome (SS) were shown to be positive for IgG and/or IgM anticardiolipin antibodies (aCL). Extraglandular manifestations were related to the IgG-, but not to the IgM-aCL. Twenty SS patients were examined over a 3 year period. Of these, 6 displayed a marked increase in IgG- and IgM-aCL and, among them, 4 developed extraglandular manifestations of SS throughout the follow-up.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060162

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  Central nervous system involvement in Sjogren's syndrome.

Authors:  F C Soliotis; C P Mavragani; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

2.  Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.

Authors:  Sharon Hassin-Baer; Yair Levy; Pnina Langevitz; Sasson Nakar; Michael Ehrenfeld
Journal:  Clin Rheumatol       Date:  2006-10-21       Impact factor: 2.980

3.  Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome.

Authors:  A Jedryka-Goral; P Jagiello; D P D'Cruz; H Maldykowa; M A Khamashta; G R Hughes; G T Swana; S Luft
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.